Evidence map›Paper›PMID 37904995›Full record

ArticlebioRxiv : the preprint server for biology2023

A neuron-specific microexon ablates the novel DNA-binding function of a histone H3K4me0 reader PHF21A.

Robert S Porter, Masayoshi Nagai, Sojin An, Maria C Gavilan, Yumie Murata-Nakamura, Katherine M Bonefas, Bo Zhou, Olivier Dionne, Jeru Manoj Manuel, Joannie St-Germain and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Masayoshi Nagai
Sojin An
Maria C Gavilan
Yumie Murata-Nakamura
Katherine M Bonefas
Bo Zhou
Olivier Dionne
Jeru Manoj Manuel
Joannie St-Germain
Liam Browning
Benoit Laurent
Uhn-Soo Cho
Shigeki Iwase
University of Michigan · USUniversité de Sherbrooke · CA

Funding

A Neuron-specific Methyl-histone Regulatory ComplexR01NS116008 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Shigeki Iwase · 2020 to 2026
$3.6M
Dissecting Histone H3K4 Methylation Enzymes in NeuroplasticityR01MH133632 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Shigeki Iwase, Michael Mark Alexander Sutton · 2024 to 2026
$2.0M
NIMH NIH HHS R01 MH133632NINDS NIH HHS R01 NS116008
6 · The paper itself

Abstract

How cell-type-specific chromatin landscapes emerge and progress during metazoan ontogenesis remains an important question. Transcription factors are expressed in a cell-type-specific manner and recruit chromatin-regulatory machinery to specific genomic loci. In contrast, chromatin-regulatory proteins are expressed broadly and are assumed to exert the same intrinsic function across cell types. However, human genetics studies have revealed an unexpected vulnerability of neurodevelopment to chromatin factor mutations with unknown mechanisms. Here, we report that 14 chromatin regulators undergo evolutionary-conserved neuron-specific splicing events involving microexons. Of the 14 chromatin regulators, two are integral components of a histone H3K4 demethylase complex; the catalytic subunit LSD1 and an H3K4me0-reader protein PHF21A adopt neuron-specific forms. We found that canonical PHF21A (PHF21A-c) binds to DNA by AT-hook motif, and the neuronal counterpart PHF21A-n lacks this DNA-binding function yet maintains H3K4me0 recognition intact. In-vitro reconstitution of the canonical and neuronal PHF21A-LSD1 complexes identified the neuronal complex as a hypomorphic H3K4 demethylating machinery with reduced nucleosome engagement. Furthermore, an autism-associated

Identifiers

PMID37904995
PMCPMC10614952
OpenAlexW4387860886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.